Stay updated on Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Sign up to get notified when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.

Latest updates to the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedLocations section updated to list participating sites by state (California, Florida, Georgia, Kansas, Maryland, Michigan, New York, Pennsylvania, Texas, Virginia) and the revision version changed to v3.3.3.SummaryDifference1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedAdded 2025 metadata entries: 2025-11-19 and 2025-11-12, along with Last Update Posted (Estimated), 2025-11, and Revision: v3.3.2. Older 2024 metadata entries—Last Update Posted, 2024-08, and Revision: v3.2.0—were removed.SummaryDifference0.3%

- Check49 days agoChange DetectedRemoved the government funding lapse notice banner related to NIH operations, which does not affect the study details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedNo additions or deletions were detected; the Study Details page content appears unchanged.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check100 days agoChange DetectedThe page now highlights Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a prior revision (v3.0.2), indicating a shift in content scope toward versioning rather than the previously listed safety topics.SummaryDifference0.3%

Stay in the know with updates to Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.